search
Back to results

New Patient-specific Functional Assessment of the Anomalous Aortic Origin of Coronary Arteries. (NECESSARY)

Primary Purpose

Anomalous Coronary Artery Origin, Anomalous Coronary Artery Arising From the Opposite Sinus, Anomalous Coronary Artery Course

Status
Recruiting
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Invasive coronary blood flow assessment and simulations and fluid dynamic patient specific simulation
Sponsored by
IRCCS Policlinico S. Donato
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Anomalous Coronary Artery Origin focused on measuring Fluid mechanics studies of circulation, Fluid mechanics studies of microcirculation, Fluid mechanics studies of transport systems, Biomechanics, Computational fluid dynamics, Hemodynamics, Mathematical modeling, Simulation, Ventricular remodeling, Tissue and organ mechanics, Mechanics of injury, Coronary congenital anomalies, Coronary blood flow assessment, Personalized functional risk assessment, Computaional fluid dynamics, Structural finite element analysis, Integration of multimodal imaging

Eligibility Criteria

14 Years - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients with a diagnosis of AAOCA of any age will undergo fluid dynamic simulation
  • Patients with age > 14 with diagnosis of AAOCA will undergo to invasive coronary flow measurements
  • Informed consent

Exclusion Criteria:

  • A presence of major associated congenital heart anomalies
  • Contraindication to the execution of the diagnostic examination requested such as age < 14 years for invasive coronary flow measurements

Sites / Locations

  • Irccs Policlinico San DonatoRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Anomalous coronary blood flow

Arm Description

Subjects suspected to have AAOCA will be submitted to angiographic coronary CT imaging to confirm the diagnosis. If the diagnosis of AAOCA will be confirmed, subjects will undergo to invasive coronary blood flow evaluation (intervention).

Outcomes

Primary Outcome Measures

Identification of myocardial ischemia on simulation model
Assess myocardial ischemia in the patient's specific model during simulated effort correlating coronary artery blood supply to myocardial oxygen demand.

Secondary Outcome Measures

Invasive coronary flow distribution assessment
Evaluation of coronary blood flow (ml/min) in anomalous coronary artery and in normal coronary artery.
Integration of different coronary artery imaging modality
CT 3D reconstruction of aorta and coronary artery with aorta and coronary artery cross-sectional area (mm2); IVUS coronary artery reconstruction cross-sectional area (mm2); coronary blood flow quantification (ml/min)
Computational fluid dynamic simulation
Correlation between at rest estimated coronary blood flow (patient's specific FSI model) and the measured invasive coronary blood flow (FFR and derived measures).
In vitro effort fluid dynamic simulation
FSI model effort will be simulated by increasing heart rate (bpm) and pressure (mmHg) that will determine changes in coronary artery cross-sectional area (mm2). The outcome of the FSI effort simulation will be measured as changes in coronary artery blood flow (ml/min)

Full Information

First Posted
November 16, 2021
Last Updated
January 10, 2023
Sponsor
IRCCS Policlinico S. Donato
Collaborators
University of Pavia
search

1. Study Identification

Unique Protocol Identification Number
NCT05159791
Brief Title
New Patient-specific Functional Assessment of the Anomalous Aortic Origin of Coronary Arteries.
Acronym
NECESSARY
Official Title
New Patient-specific Functional Assessment of the Anomalous Aortic Origin of Coronary Arteries.
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 23, 2021 (Actual)
Primary Completion Date
April 2024 (Anticipated)
Study Completion Date
July 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
IRCCS Policlinico S. Donato
Collaborators
University of Pavia

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Anomalous Aortic Origin of the Coronary Arteries (AAOCA) is a rare congenital disease that may cause sudden death in young subjects. Frequently the first and only presentation is with an acute event (such as myocardial infarction or sudden cardiac deaths) during physical effort. Not only symptoms are often absent, but also provocative tests fail to induce ischemia or related signs, showing in most patients negative results. For these limitations, the decision to undergo corrective surgery is based on the morphologic characteristics without the support of a functional evaluation. The study focused on developing a personalized ischemic risk assessment with the aid of fluid dynamic simulations. The simulation system integrate clinical data from different diagnostic sources and integrate them with coronary blood flow evaluation at rest and during simulated physical effort.
Detailed Description
Anomalous Aortic Origin of Coronary Arteries (AAOCA) is a congenital condition where one or more coronary vessels originate from an ectopic site within the aorta, such as the opposite or wrong sinus of Valsalva. Its prevalence in the general population, has been estimated between 0.03% and 0.23% depending on the variant evaluated. The anomalous left or right coronary artery, besides its origin, may take 5 different general courses: interarterial, prepulmonic, subpulmonic, retroaortic or retrocardiac. Each of these forms may be subject to cause myocardial ischemia and subsequent sudden death during physical and sport activity. In most cases, the disease is silent and does not show any symptoms before the sudden cardiac death event (SCD). Only a few AAOCA subjects report symptoms before SCD that usually occurs unexpectedly after a moderate or intense physical activity. It is extremely hard to study the causing factors in a clinical environment due to the stochastic nature of the myocardial ischemic event and the inability to reproduce the exact effort conditions. Even when a complete assessment is performed, there is no clinical exam that can reproduce sustained exercise conditions responsible for triggering ischemia and SCD. Even if such an exam would exist and provide adequate results, the risk of SCD exceeds the benefits of having a correct diagnosis. To overcome all the current diagnostic limitations the ideal diagnostic test has to investigate coronary blood supply, myocardial oxygen demand in relation to the physical activity (intensity and duration) required for triggering an ischemic event, without putting the subjects at risk. To date the only possible way to reproduce such conditions is a subject-specific virtual simulation of aortic root and coronary artery integrated with coronary blood flow simulation able to mimic pressure, flow, and oxygen demand characteristics similar to those of intense exercise, in relation to changes that anomalous coronary undergoes under such conditions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anomalous Coronary Artery Origin, Anomalous Coronary Artery Arising From the Opposite Sinus, Anomalous Coronary Artery Course, Anomalous Coronary Artery With Aortic Origin and Course Between the Great Arteries, Sudden Cardiac Death, Myocardial Ischemia
Keywords
Fluid mechanics studies of circulation, Fluid mechanics studies of microcirculation, Fluid mechanics studies of transport systems, Biomechanics, Computational fluid dynamics, Hemodynamics, Mathematical modeling, Simulation, Ventricular remodeling, Tissue and organ mechanics, Mechanics of injury, Coronary congenital anomalies, Coronary blood flow assessment, Personalized functional risk assessment, Computaional fluid dynamics, Structural finite element analysis, Integration of multimodal imaging

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Anomalous coronary blood flow
Arm Type
Experimental
Arm Description
Subjects suspected to have AAOCA will be submitted to angiographic coronary CT imaging to confirm the diagnosis. If the diagnosis of AAOCA will be confirmed, subjects will undergo to invasive coronary blood flow evaluation (intervention).
Intervention Type
Diagnostic Test
Intervention Name(s)
Invasive coronary blood flow assessment and simulations and fluid dynamic patient specific simulation
Intervention Description
The coronary blood flow and its distribution between the anomalous and normal artery will be measured by invasive coronary catheterization. Coronary artery flow will be calculated based on intravascular ultrasound (IVUS) and pressure difference measurements. After the IVUS assessment, a pressure transducer (FFR/iFR probe) will be inserted in the coronary artery for pressure measurements. The measurements will be done in the anomalous and normal coronary arteries in each patient to determine coronary flow distribution. Patient's specific heart parameters will be retrieve from CT, MRI and other diagnostic tests and integrated in the simulation module.
Primary Outcome Measure Information:
Title
Identification of myocardial ischemia on simulation model
Description
Assess myocardial ischemia in the patient's specific model during simulated effort correlating coronary artery blood supply to myocardial oxygen demand.
Time Frame
3 years
Secondary Outcome Measure Information:
Title
Invasive coronary flow distribution assessment
Description
Evaluation of coronary blood flow (ml/min) in anomalous coronary artery and in normal coronary artery.
Time Frame
During clinical diagnostic evaluation, average 3 months after
Title
Integration of different coronary artery imaging modality
Description
CT 3D reconstruction of aorta and coronary artery with aorta and coronary artery cross-sectional area (mm2); IVUS coronary artery reconstruction cross-sectional area (mm2); coronary blood flow quantification (ml/min)
Time Frame
During clinical diagnostic evaluation, average 6 months
Title
Computational fluid dynamic simulation
Description
Correlation between at rest estimated coronary blood flow (patient's specific FSI model) and the measured invasive coronary blood flow (FFR and derived measures).
Time Frame
3 years
Title
In vitro effort fluid dynamic simulation
Description
FSI model effort will be simulated by increasing heart rate (bpm) and pressure (mmHg) that will determine changes in coronary artery cross-sectional area (mm2). The outcome of the FSI effort simulation will be measured as changes in coronary artery blood flow (ml/min)
Time Frame
3 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients with a diagnosis of AAOCA of any age will undergo fluid dynamic simulation Patients with age > 14 with diagnosis of AAOCA will undergo to invasive coronary flow measurements Informed consent Exclusion Criteria: A presence of major associated congenital heart anomalies Contraindication to the execution of the diagnostic examination requested such as age < 14 years for invasive coronary flow measurements
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mauro Lo Rito, MD
Phone
+39 0252774849
Email
Mauro.lorito@grupposandonato.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mauro Lo Rito, MD
Organizational Affiliation
IRCCS Policlinico S. Donato
Official's Role
Principal Investigator
Facility Information:
Facility Name
Irccs Policlinico San Donato
City
San Donato Milanese
State/Province
MI
ZIP/Postal Code
20097
Country
Italy
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Mauro Lo Rito, MD
Phone
+39 0252774849
Email
Mauro.lorito@grupposandonato.it

12. IPD Sharing Statement

Learn more about this trial

New Patient-specific Functional Assessment of the Anomalous Aortic Origin of Coronary Arteries.

We'll reach out to this number within 24 hrs